SGLT2 INHIBITORS: CARDIOVASCULAR BENEFITS BEYOND HBA1C—TRANSLATING EVIDENCE INTO PRACTICE

Descargar Publicación
Long-term remission of type 2 diabetes—two roads to the elusive goal Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes